ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,249.66
0.31%
Dow Jones
42,793.34
0.14%
Gold vs US Dollar
2,636.355
-0.18%
Brent Oil
75.925
-0.76%
Bitcoin
101,827.88
3.56%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Daxor Corporation (DXR)

  7. Daxor Corporation (DXR) News

Daxor (DXR)

Daxor Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DXR
DateTimeSourceHeadlineSymbolCompany
18/12/202413:00GlobeNewswire Inc.Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales MomentumNASDAQ:DXRDaxor Corporation
10/12/202423:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
10/12/202423:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
10/12/202423:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
21/11/202421:00Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
09/10/202412:00GlobeNewswire Inc.DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24NASDAQ:DXRDaxor Corporation
08/10/202412:00GlobeNewswire Inc.Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitNASDAQ:DXRDaxor Corporation
27/09/202421:00GlobeNewswire Inc.Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic DeviceNASDAQ:DXRDaxor Corporation
19/09/202412:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024NASDAQ:DXRDaxor Corporation
12/09/202412:00GlobeNewswire Inc.Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome ManagementNASDAQ:DXRDaxor Corporation
05/09/202412:00GlobeNewswire Inc.Daxor Corporation Receives $300K Matching Fund Award From Launch TennesseeNASDAQ:DXRDaxor Corporation
04/09/202412:30GlobeNewswire Inc.Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient CareNASDAQ:DXRDaxor Corporation
03/09/202420:05GlobeNewswire Inc.Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder LetterNASDAQ:DXRDaxor Corporation
03/09/202416:15GlobeNewswire Inc.Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:DXRDaxor Corporation
29/08/202421:27Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
29/08/202421:16Edgar (US Regulatory)Form N-CSRS - Certified Shareholder Report, Semi-AnnualNASDAQ:DXRDaxor Corporation
29/08/202412:00GlobeNewswire Inc.Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated NetworkNASDAQ:DXRDaxor Corporation
23/08/202420:52Edgar (US Regulatory)Form 40-17G - Fidelity Bond [Rule 17G-1(g)]NASDAQ:DXRDaxor Corporation
16/08/202421:23Edgar (US Regulatory)Form N-2 - Registration statement for closed-end investment companiesNASDAQ:DXRDaxor Corporation
06/08/202412:00GlobeNewswire Inc.Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
05/08/202412:00GlobeNewswire Inc.Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum NationwideNASDAQ:DXRDaxor Corporation
24/07/202412:00GlobeNewswire Inc.Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
18/07/202418:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
17/07/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
17/07/202421:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
17/07/202421:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
17/07/202421:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
11/07/202412:00GlobeNewswire Inc.Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction NationwideNASDAQ:DXRDaxor Corporation
18/06/202412:00GlobeNewswire Inc.Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual MeetingNASDAQ:DXRDaxor Corporation
05/06/202420:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
 Showing the most relevant articles for your search:NASDAQ:DXR

Your Recent History

BIT
UC8FRE
Unicredit Bank
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads